Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CLPTM1L antibody (C-Term)

This Rabbit Polyclonal antibody specifically detects CLPTM1L in ELISA and WB. It exhibits reactivity toward Human.
Catalog No. ABIN2235091

Quick Overview for CLPTM1L antibody (C-Term) (ABIN2235091)

Target

See all CLPTM1L Antibodies
CLPTM1L (CLPTM1-Like (CLPTM1L))

Reactivity

  • 33
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Host

  • 33
Rabbit

Clonality

  • 33
Polyclonal

Conjugate

  • 13
  • 4
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This CLPTM1L antibody is un-conjugated

Application

  • 22
  • 17
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
ELISA, Western Blotting (WB)
  • Binding Specificity

    • 8
    • 7
    • 5
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    AA 369-399, C-Term

    Cross-Reactivity

    Human

    Cross-Reactivity (Details)

    Calculated cross reactivity: Hu

    Characteristics

    CLPTM1L, CT (CLPTM1L, CRR9, Cleft lip and palate transmembrane protein 1-like protein, Cisplatin resistance-related protein 9)

    Purification

    Purified by Protein A affinity chromatography.

    Immunogen

    CLPTM1L antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 369-399 amino acids from the C-terminal region of human CLPTM1L.

    Isotype

    IgG
  • Application Notes

    Optimal working conditions should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    -20 °C

    Storage Comment

    -20°C
  • Target

    CLPTM1L (CLPTM1-Like (CLPTM1L))

    Alternative Name

    CLPTM1L

    NCBI Accession

    NP_110409

    UniProt

    Q96KA5
You are here:
Chat with us!